Dr John Bashford

John Bashford

Dr John Bashford

BMedSci, MBBS (Hons 1, Qld), FRACP, FRCPA, MAICD

Clinical Haematology, Medical Oncology, Stem Cell Transplantation

Dr Bashford graduated from the University of Queensland in 1980 with a Bachelor of Medical Science and a Bachelor of Medicine/Bachelor of Surgery (Hons 1). In 1990, he completed post-graduate training in clinical haematology and medical oncology, working in Brisbane, Melbourne and the United Kingdom before returning to Queensland to undertake specialist practice.

Dr Bashford practiced clinical haematology and medical oncology at the Wesley and Mater Private Hospitals until 2018. He became a Board Director of the Wesley Clinic for Haematology and Oncology and Wesley Clinic Research Centre in 1994 and was closely involved in the commissioning of the Mater Private Centre for Haematology and Oncology in 1996. He negotiated Medicare funding for stem cell transplantation in 1996 and was director of the Wesley Hospital Stem Cell Transplant Laboratory and Clinical Programme from 1995-2017. He was Chairman of the HOCA (now Icon Group) Board from 2001-2007, negotiated the formation of Icon Group for the medical partners in 2011-2012 and has been Board Chair of Icon Cancer Foundation since 2015.

His current major professional role is Director of Icon Research and Senior Medical Consultant to Icon Group. He supervises a large portfolio of clinical trials in private cancer care across Australia and is responsible for facilitating the embedding of clinical research across Icon Group nationally and internationally.

Dr Bashford was the Foundation President of the Private Cancer Physicians of Australia (PCPA) which is a not-for-profit organisation dedicated to the improvement of the health system for all cancer patients, but particularly for private cancer patients in Australia from 2007-2010.  He has been involved in many advisory roles to Private and Public Health care groups and roles with State and Australian Government including direct ministerial negotiations around health care issues. He continues to represent professional groups and Icon Group in various settings, and is a current and active member of the Australian Institute of Company Directors.

His community activities include board roles with the Icon Cancer Foundation and Hannah’s Chance Foundation for Sarcoma Research, and a direct and fund-raising role supporting undergraduate education at the University of Queensland’s Faculty of Medicine. He has been an active clinical teacher within both the University of Queensland and Bond University.